{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T08:42:52Z","timestamp":1782636172466,"version":"3.54.5"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DBT\/CE\/F064\/2020-21\/G307"],"award-info":[{"award-number":["DBT\/CE\/F064\/2020-21\/G307"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DBT\/CE\/F064\/2020-21\/G307"],"award-info":[{"award-number":["DBT\/CE\/F064\/2020-21\/G307"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DBT\/CE\/F064\/2020-21\/G307"],"award-info":[{"award-number":["DBT\/CE\/F064\/2020-21\/G307"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DBT\/CE\/F064\/2020-21\/G307"],"award-info":[{"award-number":["DBT\/CE\/F064\/2020-21\/G307"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00384-022-04192-w","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T05:02:37Z","timestamp":1655269357000},"page":"1509-1523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The role of gut microbiota in the development of colorectal cancer: a review"],"prefix":"10.1007","volume":"37","author":[{"given":"Navami","family":"Koyande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhusree","family":"Gangopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashidhar","family":"Thatikonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind Kumar","family":"Rengan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"4192_CR1","doi-asserted-by":"publisher","unstructured":"M\u00e1rmol I, S\u00e1nchez-de-Diego C, Dieste AP et al (2017) Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci 18. https:\/\/doi.org\/10.3390\/ijms18010197","DOI":"10.3390\/ijms18010197"},{"key":"4192_CR2","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1002\/ijc.32055","volume":"144","author":"M Araghi","year":"2019","unstructured":"Araghi M, Soerjomataram I, Jenkins M et al (2019) Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer 144:2992\u20133000. https:\/\/doi.org\/10.1002\/ijc.32055","journal-title":"Int J Cancer"},{"key":"4192_CR3","doi-asserted-by":"publisher","unstructured":"Mulyawan IM (2019) Role of Ki67 protein in colorectal cancer. Int J Res Med Sci 7:644. https:\/\/doi.org\/10.18203\/2320-6012.ijrms20190374","DOI":"10.18203\/2320-6012.ijrms20190374"},{"key":"4192_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3322\/ca.2007.0018","volume":"58","author":"B Levin","year":"2008","unstructured":"Levin B, Lieberman DA, McFarland B et al (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 58:130\u2013160. https:\/\/doi.org\/10.3322\/ca.2007.0018","journal-title":"CA Cancer J Clin"},{"key":"4192_CR5","first-page":"4742","volume":"20","author":"S Bibb\u00f2","year":"2016","unstructured":"Bibb\u00f2 S, Ianiro G, Giorgio V et al (2016) The role of diet on gut microbiota composition. Eur Rev Med Pharmacol Sci 20:4742\u20134749","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4192_CR6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1152\/physrev.00045.2009","volume":"90","author":"I Sekirov","year":"2010","unstructured":"Sekirov I, Russell SL, Antunes LC, Finlay BB\u00a0(2010) Gut microbiota in health and disease. Physiol Rev 90:859\u2013904. https:\/\/doi.org\/10.1152\/physrev.00045.2009","journal-title":"Physiol Rev"},{"key":"4192_CR7","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nature06244","volume":"449","author":"PJ Turnbaugh","year":"2007","unstructured":"Turnbaugh PJ, Ley RE, Hamady M et al (2007) The human microbiome project. Nature 449:804\u2013810. https:\/\/doi.org\/10.1038\/nature06244","journal-title":"Nature"},{"key":"4192_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/eji.201444972","volume":"45","author":"A Dzutsev","year":"2015","unstructured":"Dzutsev A, Goldszmid RS, Viaud S et al (2015) The role of the microbiota in inflammation, carcinogenesis, and cancer therapy. Eur J Immunol 45:17\u201331. https:\/\/doi.org\/10.1002\/eji.201444972","journal-title":"Eur J Immunol"},{"key":"4192_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.mam.2019.05.001","volume":"69","author":"E Saus","year":"2019","unstructured":"Saus E, Iraola-Guzm\u00e1n S, Willis JR et al (2019) Microbiome and colorectal cancer: roles in carcinogenesis and clinical potential. Mol Aspects Med 69:93\u2013106. https:\/\/doi.org\/10.1016\/j.mam.2019.05.001","journal-title":"Mol Aspects Med"},{"key":"4192_CR10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nrc3610","volume":"13","author":"RF Schwabe","year":"2013","unstructured":"Schwabe RF, Jobin C (2013) The microbiome and cancer. Nat Rev Cancer 13:800\u2013812. https:\/\/doi.org\/10.1038\/nrc3610","journal-title":"Nat Rev Cancer"},{"key":"4192_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","volume":"13","author":"E Elinav","year":"2013","unstructured":"Elinav E, Nowarski R, Thaiss CA et al (2013) Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13:759\u2013771. https:\/\/doi.org\/10.1038\/nrc3611","journal-title":"Nat Rev Cancer"},{"key":"4192_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1101\/gr.126573.111","volume":"22","author":"AD Kostic","year":"2012","unstructured":"Kostic AD, Gevers D, Pedamallu CS et al (2012) Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 22:292\u2013298. https:\/\/doi.org\/10.1101\/gr.126573.111","journal-title":"Genome Res"},{"key":"4192_CR13","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/nm.2015","volume":"15","author":"S Wu","year":"2009","unstructured":"Wu S, Rhee KJ, Albesiano E et al (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15:1016\u20131022. https:\/\/doi.org\/10.1038\/nm.2015","journal-title":"Nat Med"},{"key":"4192_CR14","doi-asserted-by":"publisher","first-page":"s73","DOI":"10.1079\/bjn2002632","volume":"88","author":"CIR Gill","year":"2002","unstructured":"Gill CIR, Rowland IR (2002) Diet and cancer: assessing the risk. Br J Nutr 88:s73\u2013s87. https:\/\/doi.org\/10.1079\/bjn2002632","journal-title":"Br J Nutr"},{"key":"4192_CR15","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359\u2013E386. https:\/\/doi.org\/10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"key":"4192_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/0092-8674(90)90186-I","volume":"19","author":"EF Fearon","year":"1990","unstructured":"Fearon EF, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. G Ital Cardiol 19:170\u2013172. https:\/\/doi.org\/10.1016\/0092-8674(90)90186-I","journal-title":"G Ital Cardiol"},{"key":"4192_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s1535-6108(02)00035-1","volume":"1","author":"FT Kolligs","year":"2002","unstructured":"Kolligs FT, Nieman MT, Winer I et al (2002) ITF-2, a downstream target of the Wnt\/TCF pathway, is activated in human cancers with \u03b2-catenin defects and promotes neoplastic transformation. Cancer Cell 1:145\u2013155. https:\/\/doi.org\/10.1016\/s1535-6108(02)00035-1","journal-title":"Cancer Cell"},{"key":"4192_CR18","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cgh.2013.08.015","volume":"12","author":"EM Stoffel","year":"2014","unstructured":"Stoffel EM, Kastrinos F (2014) Familial colorectal cancer, beyond lynch syndrome. Clin Gastroenterol Hepatol 12:1059\u20131068. https:\/\/doi.org\/10.1016\/j.cgh.2013.08.015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4192_CR19","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2008.02.002","volume":"134","author":"B Levin","year":"2008","unstructured":"Levin B, Lieberman DA, McFarland B et al (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134:1570\u20131595. https:\/\/doi.org\/10.1053\/j.gastro.2008.02.002","journal-title":"Gastroenterology"},{"key":"4192_CR20","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1038\/bjc.2016.334","volume":"115","author":"A Moskal","year":"2016","unstructured":"Moskal A, Freisling H, Byrnes G et al (2016) Main nutrient patterns and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition study. Br J Cancer 115:1430\u20131440. https:\/\/doi.org\/10.1038\/bjc.2016.334","journal-title":"Br J Cancer"},{"key":"4192_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s13304-016-0359-y","volume":"68","author":"P Favoriti","year":"2016","unstructured":"Favoriti P, Carbone G, Greco M et al (2016) Worldwide burden of colorectal cancer: a review. Updates Surg 68:7\u201311. https:\/\/doi.org\/10.1007\/s13304-016-0359-y","journal-title":"Updates Surg"},{"key":"4192_CR22","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2147\/CIA.S109285","volume":"11","author":"K Simon","year":"2016","unstructured":"Simon K (2016) Colorectal cancer development and advances in screening. Clin Interv Aging 11:967\u2013976. https:\/\/doi.org\/10.2147\/CIA.S109285","journal-title":"Clin Interv Aging"},{"key":"4192_CR23","doi-asserted-by":"publisher","unstructured":"Mackie RI, Sghir A, Gaskins HR (1999) Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 69. https:\/\/doi.org\/10.1093\/ajcn\/69.5.1035s","DOI":"10.1093\/ajcn\/69.5.1035s"},{"key":"4192_CR24","doi-asserted-by":"publisher","unstructured":"Mandar R, Mikelsaar M (1996) Transmission of mothers microflora to newborn at birth. 68\u201370. https:\/\/doi.org\/10.1159\/000244275","DOI":"10.1159\/000244275"},{"key":"4192_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.chom.2008.02.015","volume":"3","author":"PJ Turnbaugh","year":"2008","unstructured":"Turnbaugh PJ, B\u00e4ckhed F, Fulton L, Gordon JI (2008) Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3:213\u2013223. https:\/\/doi.org\/10.1016\/j.chom.2008.02.015","journal-title":"Cell Host Microbe"},{"key":"4192_CR26","doi-asserted-by":"publisher","unstructured":"Eckburg PB, Bik EM, Bernstein CN et al (2005) Microbiology: diversity of the human intestinal microbial flora. Science (80- ) 308:1635\u20131638. https:\/\/doi.org\/10.1126\/science.1110591","DOI":"10.1126\/science.1110591"},{"key":"4192_CR27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3748\/wjg.v22.i2.501","volume":"22","author":"J Gagni\u00e8re","year":"2016","unstructured":"Gagni\u00e8re J, Raisch J, Veziant J et al (2016) Gut microbiota imbalance and colorectal cancer. World J Gastroenterol 22:501\u2013518. https:\/\/doi.org\/10.3748\/wjg.v22.i2.501","journal-title":"World J Gastroenterol"},{"key":"4192_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.imlet.2004.02.005","volume":"93","author":"H Tlaskalov\u00e1-Hogenov\u00e1","year":"2004","unstructured":"Tlaskalov\u00e1-Hogenov\u00e1 H, \u0160t\u011bp\u00e1nkov\u00e1 R, Hudcovic T et al (2004) Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 93:97\u2013108. https:\/\/doi.org\/10.1016\/j.imlet.2004.02.005","journal-title":"Immunol Lett"},{"key":"4192_CR29","doi-asserted-by":"publisher","first-page":"13780","DOI":"10.1073\/pnas.0706625104","volume":"104","author":"DN Frank","year":"2007","unstructured":"Frank DN, St. Amand AL, Feldman RA, et al (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104:13780\u201313785. https:\/\/doi.org\/10.1073\/pnas.0706625104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4192_CR30","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3748\/wjg.v11.i8.1131","volume":"11","author":"A Swidsinski","year":"2005","unstructured":"Swidsinski A, Loening-Baucke V, Lochs H, Hale LP (2005) Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J Gastroenterol 11:1131\u20131140. https:\/\/doi.org\/10.3748\/wjg.v11.i8.1131","journal-title":"World J Gastroenterol"},{"key":"4192_CR31","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1128\/AEM.68.7.3401-3407.2002","volume":"68","author":"EG Zoetendal","year":"2002","unstructured":"Zoetendal EG, Von Wright A, Vilpponen-Salmela T et al (2002) Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 68:3401\u20133407. https:\/\/doi.org\/10.1128\/AEM.68.7.3401-3407.2002","journal-title":"Appl Environ Microbiol"},{"key":"4192_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1757-4749-2-19","volume":"2","author":"IM Carroll","year":"2010","unstructured":"Carroll IM, Chang YH, Park J et al (2010) Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog 2:1\u20139. https:\/\/doi.org\/10.1186\/1757-4749-2-19","journal-title":"Gut Pathog"},{"key":"4192_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2016.09.049","volume":"152","author":"J Tap","year":"2017","unstructured":"Tap J, Derrien M, T\u00f6rnblom H et al (2017) Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology 152:111-123.e8. https:\/\/doi.org\/10.1053\/j.gastro.2016.09.049","journal-title":"Gastroenterology"},{"key":"4192_CR34","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/apt.13399","volume":"42","author":"I Rangel","year":"2015","unstructured":"Rangel I, Sundin J, Fuentes S et al (2015) The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects. Aliment Pharmacol Ther 42:1211\u20131221. https:\/\/doi.org\/10.1111\/apt.13399","journal-title":"Aliment Pharmacol Ther"},{"key":"4192_CR35","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2018.08.041","volume":"174","author":"N Zmora","year":"2018","unstructured":"Zmora N, Zilberman-Schapira G, Suez J et al (2018) Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 174:1388-1405.e21. https:\/\/doi.org\/10.1016\/j.cell.2018.08.041","journal-title":"Cell"},{"key":"4192_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-12-158","volume":"12","author":"S Cardona","year":"2012","unstructured":"Cardona S, Eck A, Cassellas M et al (2012) Storage conditions of intestinal microbiota matter in metagenomic analysis for standardization\/RNA and DNA degradation\/Metagenomics\/16S ribosomal RNA Background. BMC Microbiol 12:1. https:\/\/doi.org\/10.1186\/1471-2180-12-158","journal-title":"BMC Microbiol"},{"key":"4192_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1136\/gutjnl-2015-309595","volume":"66","author":"B Flemer","year":"2017","unstructured":"Flemer B, Lynch DB, Brown JMR et al (2017) Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut 66:633\u2013643. https:\/\/doi.org\/10.1136\/gutjnl-2015-309595","journal-title":"Gut"},{"key":"4192_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/gutjnl-2015-309800","volume":"66","author":"J Yu","year":"2017","unstructured":"Yu J, Feng Q, Wong SH et al (2017) Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 66:70\u201378. https:\/\/doi.org\/10.1136\/gutjnl-2015-309800","journal-title":"Gut"},{"key":"4192_CR39","doi-asserted-by":"publisher","unstructured":"Harrell L, Wang Y, Antonopoulos D et al (2012) Standard colonic lavage alters the natural state of mucosal-associated microbiota in the human colon. PLoS ONE 7. https:\/\/doi.org\/10.1371\/journal.pone.0032545","DOI":"10.1371\/journal.pone.0032545"},{"key":"4192_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1371\/journal.pone.0101344","volume":"9","author":"AE Budding","year":"2014","unstructured":"Budding AE, Grasman ME, Eck A et al (2014) Rectal swabs for analysis of the intestinal microbiota. PLoS ONE 9:5\u201312. https:\/\/doi.org\/10.1371\/journal.pone.0101344","journal-title":"PLoS ONE"},{"key":"4192_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/08910600410032367","volume":"16","author":"P Namsolleck","year":"2004","unstructured":"Namsolleck P, Thiel R, Lawson P et al (2004) Molecular methods for the analysis of gut microbiota. Microb Ecol Health Dis 16:71\u201385. https:\/\/doi.org\/10.1080\/08910600410032367","journal-title":"Microb Ecol Health Dis"},{"key":"4192_CR42","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nbt.2942","volume":"32","author":"J Li","year":"2014","unstructured":"Li J, Jia H, Cai X et al (2014) An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 32:834\u2013841. https:\/\/doi.org\/10.1038\/nbt.2942","journal-title":"Nat Biotechnol"},{"key":"4192_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"C Huttenhower","year":"2012","unstructured":"Huttenhower C, Gevers D, Knight R et al (2012) Structure, function and diversity of the healthy human microbiome. Nature 486:207\u2013214. https:\/\/doi.org\/10.1038\/nature11234","journal-title":"Nature"},{"key":"4192_CR44","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.cell.2018.02.044","volume":"172","author":"TSB Schmidt","year":"2018","unstructured":"Schmidt TSB, Raes J, Bork P (2018) The human gut microbiome: from association to modulation. Cell 172:1198\u20131215. https:\/\/doi.org\/10.1016\/j.cell.2018.02.044","journal-title":"Cell"},{"key":"4192_CR45","doi-asserted-by":"publisher","first-page":"8235","DOI":"10.1093\/nar\/9.13.3015","volume":"12","author":"S Anderson","year":"1984","unstructured":"Anderson S (1984) Shotgun DNA sequencing using cloned DNase I-generated fragments. Methods 12:8235\u20138251. https:\/\/doi.org\/10.1093\/nar\/9.13.3015","journal-title":"Methods"},{"key":"4192_CR46","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1128\/jb.173.2.697-703.1991","volume":"173","author":"WG Weisburg","year":"1991","unstructured":"Weisburg WG, Barns SM, Pelletier DA, Lane DJ (1991) 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 173:697\u2013703. https:\/\/doi.org\/10.1128\/jb.173.2.697-703.1991","journal-title":"J Bacteriol"},{"key":"4192_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2015.12.083.Analysis","volume":"63","author":"R Ranjan","year":"2016","unstructured":"Ranjan R, Rani A, McGee HS, Perkins DL (2016) Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing. Physiol Behav 63:1\u201318. https:\/\/doi.org\/10.1016\/j.bbrc.2015.12.083","journal-title":"Physiol Behav"},{"key":"4192_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4137\/EBO.S36436","volume":"12","author":"V Aguiar-Pulido","year":"2016","unstructured":"Aguiar-Pulido V, Huang W, Suarez-Ulloa V et al (2016) Metagenomics, metatranscriptomics, and metabolomics approaches for microbiome analysis. Evol Bioinforma 12:5\u201316. https:\/\/doi.org\/10.4137\/EBO.S36436","journal-title":"Evol Bioinforma"},{"key":"4192_CR49","doi-asserted-by":"publisher","unstructured":"Ranjan R, Rani A, Finn PW, Perkins DL (2018) Multiomic strategies reveal diversity and important functional aspects of human gut microbiome. Biomed Res Int 2018. https:\/\/doi.org\/10.1155\/2018\/6074918","DOI":"10.1155\/2018\/6074918"},{"key":"4192_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpba.2013.08.041","volume":"87","author":"EG Armitage","year":"2014","unstructured":"Armitage EG, Barbas C (2014) Metabolomics in cancer biomarker discovery: current trends and future perspectives. J Pharm Biomed Anal 87:1\u201311. https:\/\/doi.org\/10.1016\/j.jpba.2013.08.041","journal-title":"J Pharm Biomed Anal"},{"key":"4192_CR51","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/bjc.2016.243","volume":"115","author":"F Farshidfar","year":"2016","unstructured":"Farshidfar F, Weljie AM, Kopciuk KA et al (2016) A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics. Br J Cancer 115:848\u2013857. https:\/\/doi.org\/10.1038\/bjc.2016.243","journal-title":"Br J Cancer"},{"key":"4192_CR52","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3945\/ajcn.114.103804","volume":"102","author":"DB Liesenfeld","year":"2015","unstructured":"Liesenfeld DB, Grapov D, Fahrmann JF et al (2015) Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study. Am J Clin Nutr 102:433\u2013443. https:\/\/doi.org\/10.3945\/ajcn.114.103804","journal-title":"Am J Clin Nutr"},{"key":"4192_CR53","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1158\/1078-0432.CCR-13-1939","volume":"20","author":"Y Qiu","year":"2014","unstructured":"Qiu Y, Cai G, Zhou B et al (2014) A distinct metabolic signature of human colorectal cancer with prognostic potential. Clin Cancer Res 20:2136\u20132146. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-1939","journal-title":"Clin Cancer Res"},{"key":"4192_CR54","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1021\/pr400337b","volume":"12","author":"B Tan","year":"2013","unstructured":"Tan B, Qiu Y, Zou X et al (2013) Metabonomics identifies serum metabolite markers of colorectal cancer. J Proteome Res 12:3000\u20133009. https:\/\/doi.org\/10.1021\/pr400337b","journal-title":"J Proteome Res"},{"key":"4192_CR55","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00535-016-1261-6","volume":"52","author":"K Uchiyama","year":"2017","unstructured":"Uchiyama K, Yagi N, Mizushima K et al (2017) Serum metabolomics analysis for early detection of colorectal cancer. J Gastroenterol 52:677\u2013694. https:\/\/doi.org\/10.1007\/s00535-016-1261-6","journal-title":"J Gastroenterol"},{"key":"4192_CR56","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3978\/j.issn.2078-6891.2012.030","volume":"3","author":"M Fleming","year":"2012","unstructured":"Fleming M, Ravula S, Tatishchev SF, Wang HL (2012) Colorectal carcinoma: pathologic aspects. J Gastrointest Oncol 3:153\u2013173. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2012.030","journal-title":"J Gastrointest Oncol"},{"key":"4192_CR57","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1053\/j.gastro.2015.06.047","volume":"149","author":"JM Carethers","year":"2015","unstructured":"Carethers JM, Jung BH (2015) Genetics and genetic biomarkers in sporadic colorectal cancer. Gastroenterology 149:1177-1190.e3. https:\/\/doi.org\/10.1053\/j.gastro.2015.06.047","journal-title":"Gastroenterology"},{"key":"4192_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.615056","volume":"11","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Ling Z, Li L (2020) The intestinal microbiota and colorectal cancer. Front Immunol 11:1\u201313. https:\/\/doi.org\/10.3389\/fimmu.2020.615056","journal-title":"Front Immunol"},{"key":"4192_CR59","doi-asserted-by":"publisher","unstructured":"Marchesi JR, Dutilh BE, Hall N et al (2011) Towards the human colorectal cancer microbiome. PLoS ONE 6. https:\/\/doi.org\/10.1371\/journal.pone.0020447","DOI":"10.1371\/journal.pone.0020447"},{"key":"4192_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2015.00020","volume":"6","author":"Z Gao","year":"2015","unstructured":"Gao Z, Guo B, Gao R et al (2015) Microbiota disbiosis is associated with colorectal cancer. Front Microbiol 6:1\u20139. https:\/\/doi.org\/10.3389\/fmicb.2015.00020","journal-title":"Front Microbiol"},{"key":"4192_CR61","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s10096-017-3026-4","volume":"36","author":"R Gao","year":"2017","unstructured":"Gao R, Kong C, Huang L et al (2017) Mucosa-associated microbiota signature in colorectal cancer. Eur J Clin Microbiol Infect Dis 36:2073\u20132083. https:\/\/doi.org\/10.1007\/s10096-017-3026-4","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4192_CR62","doi-asserted-by":"publisher","unstructured":"Feng Q, Liang S, Jia et al H (2015) Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun 6. https:\/\/doi.org\/10.1038\/ncomms7528","DOI":"10.1038\/ncomms7528"},{"key":"4192_CR63","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4251\/wjgo.v10.i3.71","volume":"10","author":"FM Shang","year":"2018","unstructured":"Shang FM, Liu HL (2018) Fusobacterium nucleatum and colorectal cancer: a review. World J Gastrointest Oncol 10:71\u201381. https:\/\/doi.org\/10.4251\/wjgo.v10.i3.71","journal-title":"World J Gastrointest Oncol"},{"key":"4192_CR64","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ismej.2011.109","volume":"6","author":"T Wang","year":"2012","unstructured":"Wang T, Cai G, Qiu Y et al (2012) Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 6:320\u2013329. https:\/\/doi.org\/10.1038\/ismej.2011.109","journal-title":"ISME J"},{"key":"4192_CR65","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"TC Yu","year":"2017","unstructured":"Yu TC, Guo F, Yu Y et al (2017) Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170:548-563.e16. https:\/\/doi.org\/10.1016\/j.cell.2017.07.008","journal-title":"Cell"},{"key":"4192_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-0985-y","volume":"38","author":"S Zhang","year":"2019","unstructured":"Zhang S, Yang Y, Weng W et al (2019) Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal caner. J Exp Clin Cancer Res 38:1\u201313. https:\/\/doi.org\/10.1186\/s13046-018-0985-y","journal-title":"J Exp Clin Cancer Res"},{"key":"4192_CR67","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1136\/gut.2005.085373","volume":"55","author":"MC Arrieta","year":"2006","unstructured":"Arrieta MC, Bistritz L, Meddings JB (2006) Alterations in intestinal permeability Gut 55:1512\u20131520. https:\/\/doi.org\/10.1136\/gut.2005.085373","journal-title":"Alterations in intestinal permeability Gut"},{"key":"4192_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-014-0189-7","volume":"14","author":"SC Bischoff","year":"2014","unstructured":"Bischoff SC, Barbara G, Buurman W et al (2014) Intestinal permeability - a new target for disease prevention and therapy. BMC Gastroenterol 14:1\u201325. https:\/\/doi.org\/10.1186\/s12876-014-0189-7","journal-title":"BMC Gastroenterol"},{"key":"4192_CR69","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1053\/j.gastro.2014.03.032","volume":"146","author":"C Owyang","year":"2014","unstructured":"Owyang C, Wu GD (2014) The gut microbiome in health and disease. Gastroenterology 146:1433\u20131436. https:\/\/doi.org\/10.1053\/j.gastro.2014.03.032","journal-title":"Gastroenterology"},{"key":"4192_CR70","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ni0901-816","volume":"2","author":"KJ Maloy","year":"2001","unstructured":"Maloy KJ, Powrie F (2001) Regulatory T cells in the control of immune pathology. Nat Immunol 2:816\u2013822. https:\/\/doi.org\/10.1038\/ni0901-816","journal-title":"Nat Immunol"},{"key":"4192_CR71","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.molmed.2014.11.004","volume":"21","author":"RJ Lamont","year":"2015","unstructured":"Lamont RJ, Hajishengallis G (2015) Polymicrobial synergy and dysbiosis in inflammatory disease. Trends Mol Med 21:172\u2013183. https:\/\/doi.org\/10.1016\/j.molmed.2014.11.004","journal-title":"Trends Mol Med"},{"key":"4192_CR72","doi-asserted-by":"publisher","unstructured":"Tibbs TN, Lopez LR, Arthur JC (2019) The influence of the microbiota on immune development, chronic inflammation, and cancer in the context of aging. Microb Cell 6:324\u2013334. https:\/\/doi.org\/10.15698\/mic2019.08.685","DOI":"10.15698\/mic2019.08.685"},{"key":"4192_CR73","doi-asserted-by":"publisher","first-page":"15354","DOI":"10.1073\/pnas.1010203108","volume":"108","author":"AC Goodwin","year":"2011","unstructured":"Goodwin AC, Destefano Shields CE, Wu S et al (2011) Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci U S A 108:15354\u201315359. https:\/\/doi.org\/10.1073\/pnas.1010203108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4192_CR74","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/gast.2003.50047","volume":"124","author":"S Wu","year":"2003","unstructured":"Wu S, Morin PJ, Maouyo D, Sears CL (2003) Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 124:392\u2013400. https:\/\/doi.org\/10.1053\/gast.2003.50047","journal-title":"Gastroenterology"},{"key":"4192_CR75","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein MR, Wang X, Liu W et al (2013) Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe 14:195\u2013206. https:\/\/doi.org\/10.1016\/j.chom.2013.07.012","journal-title":"Cell Host Microbe"},{"key":"4192_CR76","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","volume":"14","author":"AD Kostic","year":"2013","unstructured":"Kostic AD, Chun E, Robertson L et al (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14:207\u2013215. https:\/\/doi.org\/10.1016\/j.chom.2013.07.007","journal-title":"Cell Host Microbe"},{"key":"4192_CR77","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1136\/gutjnl-2020-321153","volume":"69","author":"WY Cheng","year":"2020","unstructured":"Cheng WY, Wu CY, Yu J (2020) The role of gut microbiota in cancer treatment: friend or foe? Gut 69:1867\u20131876. https:\/\/doi.org\/10.1136\/gutjnl-2020-321153","journal-title":"Gut"},{"key":"4192_CR78","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.3748\/wjg.v23.i20.3632","volume":"23","author":"M Navarro","year":"2017","unstructured":"Navarro M, Nicolas A, Ferrandez A, Lanas A (2017) Colorectal cancer population screening programs worldwide in 2016: an update. World J Gastroenterol 23:3632\u20133642. https:\/\/doi.org\/10.3748\/wjg.v23.i20.3632","journal-title":"World J Gastroenterol"},{"key":"4192_CR79","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.clcc.2017.03.018","volume":"16","author":"J Zhang","year":"2017","unstructured":"Zhang J, Cheng Z, Ma Y et al (2017) Effectiveness of screening modalities in colorectal cancer: a network meta-analysis. Clin Colorectal Cancer 16:252\u2013263. https:\/\/doi.org\/10.1016\/j.clcc.2017.03.018","journal-title":"Clin Colorectal Cancer"},{"key":"4192_CR80","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrgastro.2013.178","volume":"10","author":"SR Konstantinov","year":"2013","unstructured":"Konstantinov SR, Kuipers EJ, Peppelenbosch MP (2013) Functional genomic analyses of the gut microbiota for crc screening. Nat Rev Gastroenterol Hepatol 10:741\u2013745. https:\/\/doi.org\/10.1038\/nrgastro.2013.178","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4192_CR81","doi-asserted-by":"publisher","unstructured":"Zeller G, Tap J, Voigt AY et al (2014) Potential of fecal microbiota for early\u2010stage detection of colorectal cancer. Mol Syst Biol 10:766. https:\/\/doi.org\/10.15252\/msb.20145645","DOI":"10.15252\/msb.20145645"},{"key":"4192_CR82","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mimet.2018.11.007","volume":"155","author":"S Rezasoltani","year":"2018","unstructured":"Rezasoltani S, Sharafkhah M, Asadzadeh Aghdaei H et al (2018) Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer. J Microbiol Methods 155:82\u201388. https:\/\/doi.org\/10.1016\/j.mimet.2018.11.007","journal-title":"J Microbiol Methods"},{"key":"4192_CR83","doi-asserted-by":"publisher","unstructured":"Ai L, Tian H, Chen Z et al (2017) Systematic evaluation of supervised classifiers for fecal microbiota-based prediction of colorectal cancer. Oncotarget 8:9546\u20139556. https:\/\/doi.org\/10.18632\/oncotarget.14488","DOI":"10.18632\/oncotarget.14488"},{"key":"4192_CR84","doi-asserted-by":"publisher","first-page":"299","DOI":"10.7554\/eLife.25801","volume":"7","author":"M Castellarin","year":"2018","unstructured":"Castellarin M, Warren R, Douglas F, Dreolini L (2018) Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Elife 7:299\u2013306. https:\/\/doi.org\/10.1101\/gr.126516.111","journal-title":"Elife"},{"key":"4192_CR85","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s10096-014-2081-3","volume":"33","author":"L Flanagan","year":"2014","unstructured":"Flanagan L, Schmid J, Ebert M et al (2014) Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis 33:1381\u20131390. https:\/\/doi.org\/10.1007\/s10096-014-2081-3","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4192_CR86","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40168-018-0451-2","volume":"6","author":"Z Dai","year":"2018","unstructured":"Dai Z, Coker OO, Nakatsu G et al (2018) Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Microbiome 6:70. https:\/\/doi.org\/10.1186\/s40168-018-0451-2","journal-title":"Microbiome"},{"key":"4192_CR87","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1136\/gutjnl-2016-313189","volume":"67","author":"MS Shah","year":"2018","unstructured":"Shah MS, DeSantis TZ, Weinmaier T et al (2018) Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer. Gut 67:882\u2013891. https:\/\/doi.org\/10.1136\/gutjnl-2016-313189","journal-title":"Gut"},{"key":"4192_CR88","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0002-9440(10)61172-8","volume":"160","author":"E Balish","year":"2002","unstructured":"Balish E, Warner T (2002) Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol 160:2253\u20132257. https:\/\/doi.org\/10.1016\/S0002-9440(10)61172-8","journal-title":"Am J Pathol"},{"key":"4192_CR89","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-020-00531-8","author":"TA D\u2019asheesh","year":"2020","unstructured":"D\u2019asheesh TA, Hussen BM, Al-Marzoqi AH, Ghasemian A (2020) Assessment of oncogenic role of intestinal microbiota in colorectal cancer patients. J Gastrointest Cancer. https:\/\/doi.org\/10.1007\/s12029-020-00531-8","journal-title":"J Gastrointest Cancer"},{"key":"4192_CR90","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1542\/peds.2010-2548","volume":"126","author":"DW Thomas","year":"2010","unstructured":"Thomas DW, Greer FR, Bhatia JJS et al (2010) Clinical report - probiotics and prebiotics in pediatrics. Pediatrics 126:1217\u20131231. https:\/\/doi.org\/10.1542\/peds.2010-2548","journal-title":"Pediatrics"},{"key":"4192_CR91","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/ybega.2004.443","volume":"18","author":"E Isolauri","year":"2019","unstructured":"Isolauri E, Salminen S, Ouwehand AC (2019) Probiotics. Compr Biotechnol 18:649\u2013661. https:\/\/doi.org\/10.1053\/ybega.2004.443","journal-title":"Compr Biotechnol"},{"key":"4192_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.copbio.2015.09.001.Prebiotics","volume":"37","author":"RW Hutkins","year":"2016","unstructured":"Hutkins RW, Krumbeck JA, Bindels LB et al (2016) Prebiotics \u2013 why definitions matter. Curr Oin Biotechnol 37:1\u20137. https:\/\/doi.org\/10.1016\/j.copbio.2015.09.001","journal-title":"Curr Oin Biotechnol"},{"key":"4192_CR93","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/nejmra1600266","volume":"375","author":"SV Lynch","year":"2016","unstructured":"Lynch SV, Pedersen O (2016) The human intestinal microbiome in health and disease. N Engl J Med 375:2369\u20132379. https:\/\/doi.org\/10.1056\/nejmra1600266","journal-title":"N Engl J Med"},{"key":"4192_CR94","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1056\/nejmc1803103","volume":"378","author":"FE Juul","year":"2018","unstructured":"Juul FE, Garborg K, Bretthauer M et al (2018) Fecal microbiota transplantation for primary clostridium difficile infection. N Engl J Med 378:2535\u20132536. https:\/\/doi.org\/10.1056\/nejmc1803103","journal-title":"N Engl J Med"},{"key":"4192_CR95","doi-asserted-by":"publisher","unstructured":"Filip M, Tzaneva V, Dumitrascu DANL (2018) Fecal transplantation\u202f: digestive and extradigestive clinical applications Intestinal microbiota. 91:259\u2013265. https:\/\/doi.org\/10.15386\/cjmed-946","DOI":"10.15386\/cjmed-946"},{"key":"4192_CR96","doi-asserted-by":"publisher","unstructured":"Rosshart SP, Vassallo BG, Angeletti D et al (2017) Wild mouse gut microbiota promotes host fitness and improves disease resistance article wild mouse gut microbiota promotes host fitness and improves disease resistance. Cell 1\u201314. https:\/\/doi.org\/10.1016\/j.cell.2017.09.016","DOI":"10.1016\/j.cell.2017.09.016"},{"key":"4192_CR97","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1053\/j.gastro.2017.08.022","volume":"153","author":"SH Wong","year":"2017","unstructured":"Wong SH, Zhao L, Zhang X et al (2017) Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice. Gastroenterology 153:1621-1633.e6. https:\/\/doi.org\/10.1053\/j.gastro.2017.08.022","journal-title":"Gastroenterology"},{"key":"4192_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjgast-2016-000087","volume":"3","author":"H Sbahi","year":"2016","unstructured":"Sbahi H, Di Palma JA (2016) Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. BMJ Open Gastroenterol 3:1\u20137. https:\/\/doi.org\/10.1136\/bmjgast-2016-000087","journal-title":"BMJ Open Gastroenterol"},{"key":"4192_CR99","doi-asserted-by":"publisher","unstructured":"Bullman S, Pedamallu CS, Sicinska E et al (2017) Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science (80- ) 358:1443\u20131448. https:\/\/doi.org\/10.1126\/science.aal5240","DOI":"10.1126\/science.aal5240"},{"key":"4192_CR100","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1002\/ijc.30643","volume":"140","author":"H Cao","year":"2017","unstructured":"Cao H, Xu M, Dong W et al (2017) Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis. Int J Cancer 140:2545\u20132556. https:\/\/doi.org\/10.1002\/ijc.30643","journal-title":"Int J Cancer"},{"key":"4192_CR101","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1158\/2159-8290.CD-14-0501","volume":"4","author":"DR Donohoe","year":"2014","unstructured":"Donohoe DR, Holley D, Collins LB et al (2014) A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov 4:1387\u20131397. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0501","journal-title":"Cancer Discov"},{"key":"4192_CR102","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41551-017-0181-y","volume":"2","author":"CL Ho","year":"2018","unstructured":"Ho CL, Tan HQ, Chua KJ et al (2018) Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention. Nat Biomed Eng 2:27\u201337. https:\/\/doi.org\/10.1038\/s41551-017-0181-y","journal-title":"Nat Biomed Eng"},{"key":"4192_CR103","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1080\/15384047.2017.1345396","volume":"18","author":"ER Camp","year":"2017","unstructured":"Camp ER, Patterson LD, Kester M, Voelkel-Johnson C (2017) Therapeutic implications of bioactive sphingolipids: a focus on colorectal cancer. Cancer Biol Ther 18:640\u2013650. https:\/\/doi.org\/10.1080\/15384047.2017.1345396","journal-title":"Cancer Biol Ther"},{"key":"4192_CR104","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.ccell.2015.11.010","volume":"28","author":"NR West","year":"2015","unstructured":"West NR, Powrie F (2015) Immunotherapy not working? Check your microbiota. Cancer Cell 28:687\u2013689. https:\/\/doi.org\/10.1016\/j.ccell.2015.11.010","journal-title":"Cancer Cell"},{"key":"4192_CR105","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4161\/gmic.23919","volume":"4","author":"M Raman","year":"2013","unstructured":"Raman M, Ambalam P, Kondepudi KK et al (2013) Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer. Gut Microbes 4:181\u2013192. https:\/\/doi.org\/10.4161\/gmic.23919","journal-title":"Gut Microbes"},{"key":"4192_CR106","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/01635581.2012.700758","volume":"64","author":"J Escamilla","year":"2012","unstructured":"Escamilla J, Lane MA, Maitin V (2012) Cell-free supernatants from probiotic lactobacillus casei and lactobacillus rhamnosus GG decrease colon cancer cell invasion in vitro. Nutr Cancer 64:871\u2013878. https:\/\/doi.org\/10.1080\/01635581.2012.700758","journal-title":"Nutr Cancer"},{"key":"4192_CR107","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000494052","volume":"100","author":"C Lin","year":"2019","unstructured":"Lin C, Cai X, Zhang J et al (2019) Role of gut microbiota in the development and treatment of colorectal cancer. Digestion 100:72\u201378. https:\/\/doi.org\/10.1159\/000494052","journal-title":"Digestion"},{"key":"4192_CR108","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2217\/fmb.15.66","volume":"10","author":"ZF Chen","year":"2015","unstructured":"Chen ZF, Ai LY, Wang JL et al (2015) Probiotics Clostridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis. Future Microbiol 10:1433\u20131445. https:\/\/doi.org\/10.2217\/fmb.15.66","journal-title":"Future Microbiol"},{"key":"4192_CR109","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s00535-015-1158-9","volume":"51","author":"M Lenoir","year":"2016","unstructured":"Lenoir M, del Carmen S, Cortes-Perez NG et al (2016) Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer. J Gastroenterol 51:862\u2013873. https:\/\/doi.org\/10.1007\/s00535-015-1158-9","journal-title":"J Gastroenterol"},{"key":"4192_CR110","doi-asserted-by":"publisher","unstructured":"Konishi H, Fujiya M, Tanaka H et al (2016) Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis. Nat Commun 7. https:\/\/doi.org\/10.1038\/ncomms12365","DOI":"10.1038\/ncomms12365"},{"key":"4192_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2018.00983","volume":"9","author":"CW Chang","year":"2018","unstructured":"Chang CW, Liu CY, Lee HC et al (2018) Lactobacillus casei variety rhamnosus probiotic preventively attenuates 5-fluorouracil\/oxaliplatin-induced intestinal injury in a syngeneic colorectal cancer model. Front Microbiol 9:1\u201315. https:\/\/doi.org\/10.3389\/fmicb.2018.00983","journal-title":"Front Microbiol"},{"key":"4192_CR112","doi-asserted-by":"publisher","first-page":"227","DOI":"10.5152\/tjg.2016.15375","volume":"27","author":"S Liang","year":"2016","unstructured":"Liang S, Xu L, Zhang D, Wu Z (2016) Effect of probiotics on small intestinal bacterial overgrowth in patients with gastric and colorectal cancer. Turkish J Gastroenterol 27:227\u2013232. https:\/\/doi.org\/10.5152\/tjg.2016.15375","journal-title":"Turkish J Gastroenterol"},{"key":"4192_CR113","doi-asserted-by":"publisher","unstructured":"Cousin FJ, Jouan-Lanhouet S, Th\u00e9ret N et al (2016) The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer. Oncotarget 7:7161\u20137178. https:\/\/doi.org\/10.18632\/oncotarget.6881","DOI":"10.18632\/oncotarget.6881"},{"key":"4192_CR114","doi-asserted-by":"publisher","first-page":"7577","DOI":"10.1007\/s13197-015-1921-1","volume":"52","author":"KR Pandey","year":"2015","unstructured":"Pandey KR, Naik SR, Vakil BV (2015) Probiotics, prebiotics and synbiotics- a review. J Food Sci Technol 52:7577\u20137587. https:\/\/doi.org\/10.1007\/s13197-015-1921-1","journal-title":"J Food Sci Technol"},{"key":"4192_CR115","doi-asserted-by":"publisher","first-page":"205031211982578","DOI":"10.1177\/2050312119825784","volume":"7","author":"HS Bozkurt","year":"2019","unstructured":"Bozkurt HS, Quigley EM, Kara B (2019) Bifidobacterium animalis subspecies lactis engineered to produce mycosporin-like amino acids in colorectal cancer prevention. SAGE Open Med 7:205031211982578. https:\/\/doi.org\/10.1177\/2050312119825784","journal-title":"SAGE Open Med"},{"key":"4192_CR116","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.2147\/OTT.S170626","volume":"11","author":"C Ding","year":"2018","unstructured":"Ding C, Tang W, Fan X, Wu G (2018) Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics. Onco Targets Ther 11:4797\u20134810. https:\/\/doi.org\/10.2147\/OTT.S170626","journal-title":"Onco Targets Ther"},{"key":"4192_CR117","doi-asserted-by":"publisher","unstructured":"Zitvogel L, Ma Y, Raoult D et al (2018) The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies. Science (80- ) 359:1366\u20131370. https:\/\/doi.org\/10.1126\/science.aar6918","DOI":"10.1126\/science.aar6918"},{"key":"4192_CR118","doi-asserted-by":"publisher","unstructured":"Routy B, Le Chatelier E, Derosa L et al (2018) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science (80- ) 359:91\u201397. https:\/\/doi.org\/10.1126\/science.aan3706","DOI":"10.1126\/science.aan3706"},{"key":"4192_CR119","doi-asserted-by":"publisher","unstructured":"Matson V, Fessler J, Bao R et al (2018) The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science (80- ) 359:104\u2013108. https:\/\/doi.org\/10.1126\/science.aao3290","DOI":"10.1126\/science.aao3290"},{"key":"4192_CR120","doi-asserted-by":"publisher","unstructured":"Sivan A, Corrales L, Hubert N et al (2015) Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science (80- ) 350:1084\u20131089. https:\/\/doi.org\/10.1126\/science.aac4255","DOI":"10.1126\/science.aac4255"},{"key":"4192_CR121","doi-asserted-by":"publisher","unstructured":"V\u00e9tizou M, Pitt JM, Daill\u00e8re R et al (2015) Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science (80- ) 350:1079\u20131084. https:\/\/doi.org\/10.1126\/science.aad1329","DOI":"10.1126\/science.aad1329"},{"key":"4192_CR122","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.immuni.2016.09.009","volume":"45","author":"R Daill\u00e8re","year":"2016","unstructured":"Daill\u00e8re R, V\u00e9tizou M, Waldschmitt N et al (2016) Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity 45:931\u2013943. https:\/\/doi.org\/10.1016\/j.immuni.2016.09.009","journal-title":"Immunity"},{"key":"4192_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2217\/imt.15.97","volume":"8","author":"V Lee","year":"2016","unstructured":"Lee V, Le DT (2016) Efficacy of PD-1 blockade in tumors with MMR deficiency. Immunotherapy 8:1\u20133. https:\/\/doi.org\/10.2217\/imt.15.97","journal-title":"Immunotherapy"},{"key":"4192_CR124","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1159\/000091441","volume":"22","author":"S Goyle","year":"2006","unstructured":"Goyle S, Maraveyas A (2006) Chemotherapy for colorectal cancer. Dig Surg 22:401\u2013414. https:\/\/doi.org\/10.1159\/000091441","journal-title":"Dig Surg"},{"key":"4192_CR125","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/S0959-8049(98)00058-6","volume":"34","author":"M Miwa","year":"1998","unstructured":"Miwa M, Ura M, Nishida M et al (1998) Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5 fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 34:1274\u20131281. https:\/\/doi.org\/10.1016\/S0959-8049(98)00058-6","journal-title":"Eur J Cancer"},{"key":"4192_CR126","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clinthera.2005.01.005","volume":"27","author":"CM Walko","year":"2005","unstructured":"Walko CM, Lindley C (2005) Capecitabine: a review. Clin Ther 27:23\u201344. https:\/\/doi.org\/10.1016\/j.clinthera.2005.01.005","journal-title":"Clin Ther"},{"key":"4192_CR127","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573\u2013584. https:\/\/doi.org\/10.1038\/nrc2167","journal-title":"Nat Rev Cancer"},{"key":"4192_CR128","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ctrv.2006.07.001","volume":"32","author":"C Fuchs","year":"2006","unstructured":"Fuchs C, Mitchell EP, Hoff PM (2006) Irinotecan in the treatment of colorectal cancer. Cancer Treat Rev 32:491\u2013503. https:\/\/doi.org\/10.1016\/j.ctrv.2006.07.001","journal-title":"Cancer Treat Rev"},{"key":"4192_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21144919","volume":"21","author":"M Kciuk","year":"2020","unstructured":"Kciuk M, Marciniak B, Kontek R (2020) Irinotecan\u2014still an important player in cancer chemotherapy: A comprehensive overview. Int J Mol Sci 21:1\u201321. https:\/\/doi.org\/10.3390\/ijms21144919","journal-title":"Int J Mol Sci"},{"key":"4192_CR130","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nrclinonc.2015.129","volume":"12","author":"C Cremolini","year":"2015","unstructured":"Cremolini C, Schirripa M, Antoniotti C et al (2015) First-line chemotherapy for mCRC-a review and evidence-based algorithm. Nat Rev Clin Oncol 12:607\u2013619. https:\/\/doi.org\/10.1038\/nrclinonc.2015.129","journal-title":"Nat Rev Clin Oncol"},{"key":"4192_CR131","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3109\/03602532.2011.638303","volume":"44","author":"JJG Marin","year":"2012","unstructured":"Marin JJG, Sanchez De Medina F, Cast\u00e3o B et al (2012) Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer. Drug Metab Rev 44:148\u2013172. https:\/\/doi.org\/10.3109\/03602532.2011.638303","journal-title":"Drug Metab Rev"},{"key":"4192_CR132","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jff.2018.06.011","volume":"47","author":"M Lin","year":"2018","unstructured":"Lin M, Zhang J, Chen X (2018) Bioactive flavonoids in Moringa oleifera and their health-promoting properties. J Funct Foods 47:469\u2013479. https:\/\/doi.org\/10.1016\/j.jff.2018.06.011","journal-title":"J Funct Foods"},{"key":"4192_CR133","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbrc.2021.11.071","volume":"586","author":"R Raghavan","year":"2022","unstructured":"Raghavan R, Koyande N, Beher R et al (2022) Plakophilin3 loss leads to increased adenoma formation and rectal prolapse in APCmin mice. Biochem Biophys Res Commun 586:14\u201319. https:\/\/doi.org\/10.1016\/j.bbrc.2021.11.071","journal-title":"Biochem Biophys Res Commun"},{"key":"4192_CR134","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/ijc.33711","volume":"149","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary N, Choudhary BS, Shah SG et al (2021) Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer. Int J Cancer 149:1495\u20131511. https:\/\/doi.org\/10.1002\/ijc.33711","journal-title":"Int J Cancer"},{"key":"4192_CR135","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1158\/0008-5472.CAN-09-3953","volume":"70","author":"P Cammareri","year":"2010","unstructured":"Cammareri P, Scopelliti A, Todaro M et al (2010) Aurora-A is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells. Cancer Res 70:4655\u20134665. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3953","journal-title":"Cancer Res"},{"key":"4192_CR136","doi-asserted-by":"publisher","unstructured":"Tsoumas D, Nikou S, Giannopoulou E et al (2018) ILK expression in colorectal cancer is associated with EMT, cancer stem cell markers and chemoresistance. Cancer Genom Proteom 15:127\u2013141. https:\/\/doi.org\/10.21873\/cgp.20071","DOI":"10.21873\/cgp.20071"},{"key":"4192_CR137","doi-asserted-by":"publisher","unstructured":"Wasserman I, Lee LH, Ogino S et al (2018) (SMAD4 loss in colorectal cancer patients correlates with recurrence, loss of immune infiltrate, and chemoresistance. 2015 IEEE Summer Top Meet Ser SUM 2015 10:1\u201313. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1726","DOI":"10.1158\/1078-0432.CCR-18-1726"},{"key":"4192_CR138","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1002\/stem.2668","volume":"35","author":"D Izumi","year":"2017","unstructured":"Izumi D, Ishimoto T, Miyake K et al (2017) Colorectal cancer stem cells acquire chemoresistance through the upregulation of F-Box\/WD repeat-containing protein 7 and the consequent degradation of c-Myc. Stem Cells 35:2027\u20132036. https:\/\/doi.org\/10.1002\/stem.2668","journal-title":"Stem Cells"},{"key":"4192_CR139","doi-asserted-by":"publisher","unstructured":"Iida N, Dzutsev A, Stewart CA et al (2013) Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science (80- ) 342:967\u2013970. https:\/\/doi.org\/10.1126\/science.1240527","DOI":"10.1126\/science.1240527"},{"key":"4192_CR140","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.biopha.2018.08.165","volume":"108","author":"L Yuan","year":"2018","unstructured":"Yuan L, Zhang S, Li H et al (2018) The influence of gut microbiota dysbiosis to the efficacy of 5-fluorouracil treatment on colorectal cancer. Biomed Pharmacother 108:184\u2013193. https:\/\/doi.org\/10.1016\/j.biopha.2018.08.165","journal-title":"Biomed Pharmacother"},{"key":"4192_CR141","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.cell.2017.07.018","volume":"170","author":"A Ramos","year":"2017","unstructured":"Ramos A, Hemann MT (2017) Drugs, bugs, and cancer: Fusobacterium nucleatum promotes chemoresistance in colorectal cancer. Cell 170:411\u2013413. https:\/\/doi.org\/10.1016\/j.cell.2017.07.018","journal-title":"Cell"},{"key":"4192_CR142","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1158\/0008-5472.CAN-05-3948","volume":"66","author":"MG Kelly","year":"2006","unstructured":"Kelly MG, Alvero AB, Chen R et al (2006) TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res 66:3859\u20133868. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-3948","journal-title":"Cancer Res"},{"key":"4192_CR143","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1080\/14737159.2018.1544495","volume":"18","author":"ATF Choy","year":"2018","unstructured":"Choy ATF, Carnevale I, Coppola S et al (2018) The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of gemcitabine. Expert Rev Mol Diagn 18:1005\u20131009. https:\/\/doi.org\/10.1080\/14737159.2018.1544495","journal-title":"Expert Rev Mol Diagn"},{"key":"4192_CR144","doi-asserted-by":"publisher","first-page":"13054","DOI":"10.1074\/jbc.M114.558924","volume":"289","author":"VJ Vande","year":"2014","unstructured":"Vande VJ, Sabuncuo\u01e7lu S, Noppen S et al (2014) Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine. J Biol Chem 289:13054\u201313065. https:\/\/doi.org\/10.1074\/jbc.M114.558924","journal-title":"J Biol Chem"},{"key":"4192_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep14554","volume":"5","author":"P Lehouritis","year":"2015","unstructured":"Lehouritis P, Cummins J, Stanton M et al (2015) Local bacteria affect the efficacy of chemotherapeutic drugs. Sci Rep 5:1\u201312. https:\/\/doi.org\/10.1038\/srep14554","journal-title":"Sci Rep"},{"key":"4192_CR146","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.fob.2015.07.007","volume":"5","author":"J Vande Voorde","year":"2015","unstructured":"Vande Voorde J, Vervaeke P, Liekens S, Balzarini J (2015) Mycoplasma hyorhinis-encoded cytidine deaminase efficiently inactivates cytosine-based anticancer drugs. FEBS Open Bio 5:634\u2013639. https:\/\/doi.org\/10.1016\/j.fob.2015.07.007","journal-title":"FEBS Open Bio"},{"key":"4192_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01198-5","author":"Y Liu","year":"2020","unstructured":"Liu Y, Baba Y, Ishimoto T et al (2020) Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma. Br J Cancer. https:\/\/doi.org\/10.1038\/s41416-020-01198-5","journal-title":"Br J Cancer"},{"key":"4192_CR148","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"1160","author":"LT Geller","year":"2017","unstructured":"Geller LT, Barzily-rokni M, Danino T et al (2017) Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine Leore 1160:1156\u20131160. https:\/\/doi.org\/10.1126\/science.aah5043","journal-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine Leore"},{"key":"4192_CR149","unstructured":"Solomon SL, Oliver B, Disease C (2014) Antibiotic resistance threats in the United States: stepping back from the brink. American family physician, 89(12), 938\u2013941."},{"key":"4192_CR150","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.addr.2005.04.004","volume":"57","author":"A Kumar","year":"2005","unstructured":"Kumar A, Schweizer HP (2005) Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev 57:1486\u20131513. https:\/\/doi.org\/10.1016\/j.addr.2005.04.004","journal-title":"Adv Drug Deliv Rev"},{"key":"4192_CR151","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1089\/107662903322286463","volume":"9","author":"N Ruiz","year":"2003","unstructured":"Ruiz N, Montero T, Hernandez-Borrell J, Vi\u00f1as M (2003) The role of Serratia marcescens porins in antibiotic resistance. Microb Drug Resist 9:257\u2013264. https:\/\/doi.org\/10.1089\/107662903322286463","journal-title":"Microb Drug Resist"},{"key":"4192_CR152","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/146837a0","volume":"146","author":"EP Abraham","year":"1940","unstructured":"Abraham EP, Chain E (1940) An enzyme from bacteria able to. Nature 146:837. https:\/\/doi.org\/10.1038\/146837a0","journal-title":"Nature"},{"key":"4192_CR153","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1007\/s00018-004-4060-9","volume":"61","author":"K Poole","year":"2004","unstructured":"Poole K (2004) Resistance to \u03b2-lactam antibiotics. Cell Mol Life Sci 61:2200\u20132223. https:\/\/doi.org\/10.1007\/s00018-004-4060-9","journal-title":"Cell Mol Life Sci"},{"key":"4192_CR154","doi-asserted-by":"publisher","unstructured":"Levy SB (2002) Active efflux, a common mechanism for biocide and antibiotic resistance. Symp Ser Soc Appl Microbiol 65\u201371.  https:\/\/doi.org\/10.1046\/j.1365-2672.92.5s1.4.x","DOI":"10.1046\/j.1365-2672.92.5s1.4.x"},{"key":"4192_CR155","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/07853890701195262","volume":"39","author":"K Poole","year":"2007","unstructured":"Poole K (2007) Efflux pumps as antimicrobial resistance mechanisms. Ann Med 39:162\u2013176. https:\/\/doi.org\/10.1080\/07853890701195262","journal-title":"Ann Med"},{"key":"4192_CR156","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.femsle.2005.02.034","volume":"245","author":"MC Roberts","year":"2005","unstructured":"Roberts MC (2005) Update on acquired tetracycline resistance genes. FEMS Microbiol Lett 245:195\u2013203. https:\/\/doi.org\/10.1016\/j.femsle.2005.02.034","journal-title":"FEMS Microbiol Lett"},{"key":"4192_CR157","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/jac\/dkt002","volume":"68","author":"S Schelenz","year":"2013","unstructured":"Schelenz S, Nwaka D, Hunter PR (2013) Longitudinal surveillance of bacteraemia in haematology and oncology patients at a uk cancer centre and the impact of ciprofloxacin use on antimicrobial resistance. J Antimicrob Chemother 68:1431\u20131438. https:\/\/doi.org\/10.1093\/jac\/dkt002","journal-title":"J Antimicrob Chemother"},{"key":"4192_CR158","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0065-7743(08)60495-9","volume":"17","author":"JM Munita","year":"2015","unstructured":"Munita JM, Arias CA (2015) Mechanisms of antibiotic resistance. Annu Rep Med Chem 17:119\u2013127. https:\/\/doi.org\/10.1128\/microbiolspec.VMBF-0016-2015","journal-title":"Annu Rep Med Chem"},{"key":"4192_CR159","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.arcmed.2017.11.004","volume":"48","author":"T Iizumi","year":"2017","unstructured":"Iizumi T, Battaglia T, Ruiz V, Perez Perez GI (2017) Gut microbiome and antibiotics. Arch Med Res 48:727\u2013734. https:\/\/doi.org\/10.1016\/j.arcmed.2017.11.004","journal-title":"Arch Med Res"},{"key":"4192_CR160","doi-asserted-by":"publisher","unstructured":"Holman DB, Ch\u00e9nie MR (2012) Antimicrobial use in swine production and its effect on the swine gut microbiota and antimicrobial resistance. Journal 348\u2013349. https:\/\/doi.org\/10.1139\/cjm-2015-0239","DOI":"10.1139\/cjm-2015-0239"},{"key":"4192_CR161","doi-asserted-by":"publisher","unstructured":"Korpela K, Salonen A, Virta LJ et al (2016) Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun 7. https:\/\/doi.org\/10.1038\/ncomms10410","DOI":"10.1038\/ncomms10410"},{"key":"4192_CR162","doi-asserted-by":"crossref","unstructured":"Rutter MD, Nickerson C, Rees CJ, et al (2014) Risk factors for adverse events related to polypectomy in the english bowel cancer screening programme. Endoscopy 46:90\u201397. https:\/\/doi.org\/10.1055\/s-0033-1344987","DOI":"10.1055\/s-0033-1344987"},{"key":"4192_CR163","doi-asserted-by":"publisher","unstructured":"Lee J, LILES E, Bent S (2011) Accuracy of Fecal Immunochemical Tests for Colorectal Cancer: Systematic Review and Meta-analysis. Bone 23:1\u20137. https:\/\/doi.org\/10.7326\/M13-1484","DOI":"10.7326\/M13-1484"},{"key":"4192_CR164","doi-asserted-by":"publisher","unstructured":"Robertson DJ, Lee JK, Boland CR, et al (2017) Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: A consensus statement by the US multi-society task force on colorectal cancer. Gastroenterology 152:1217-1237.e3. https:\/\/doi.org\/10.1053\/j.gastro.2016.08.053","DOI":"10.1053\/j.gastro.2016.08.053"},{"key":"4192_CR165","doi-asserted-by":"publisher","unstructured":"Coghlin C, Murray G (2015) Biomarkers of colorectal cancer: recent advances and future challenges. 1\u201324. https:\/\/doi.org\/10.1002\/prca.201400082","DOI":"10.1002\/prca.201400082"},{"key":"4192_CR166","doi-asserted-by":"publisher","unstructured":"Pouncey AL, Scott AJ, Alexander JL et al (2018) Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment. ecancermedicalscience\u00a012:1\u20139. https:\/\/doi.org\/10.3332\/ecancer.2018.868","DOI":"10.3332\/ecancer.2018.868"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-022-04192-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-022-04192-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-022-04192-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T10:21:20Z","timestamp":1657189280000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-022-04192-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":166,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["4192"],"URL":"https:\/\/doi.org\/10.1007\/s00384-022-04192-w","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"assertion":[{"value":"21 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}